Bronchial provocation challenges with exercise and methacholine were performed on the same day or within a short interval in 52 children with asthma, 22
Asthma is the most common important chronic disease of childhood and affects 10- 20% of all school age children.`5 It is not, however, the only chronic lung disease of childhood or the only chronic lung disease to cause chronic airway obstruction. Other important conditions causing chronic lung disease in children include cystic fibrosis, the immotile cilia syndrome, postviral bronchiolitis obliterans, and bronchiectasis. Bronchial hyperreactivity to non-specific stimuli, such as inhalation of methacholine or histamine, exercise, isocapnic hyperventilation, or inhalation of non-isotonic fogs, is generally regarded as an important hallmark of asthmaS'0; it has even been suggested that the lack of a positive response to methacholine invalidates the clinical diagnosis. 11 Increased bronchial reactivity to exercise and bronchoconstrictor mediators has, however, been reported in children with cystic fibrosis"-5 and in adults increased reactivity to constrictor mediators has been found in normal subjects and some adults with chronic bronchitis and various other conditions, as pointed out by Britton and Tattersfield.16 These authors concluded that "it seems inherently unlikely that bronchial challenge tests will provide a clear distinction between asthmatic and non-asthmatic subjects." Ramsdale and colleagues, '7 18 however, showed that adults with chronic bronchitis and asthma were hyperresponsive to methacholine inhalation but in general only the asthmatic subjects responded to isocapnic hyperventilation.
Hyperreactivity to inhaled constrictor mediators may differ in its pathophysiological pathway from that of exercise or hyperventilation and these differences might be clinically relevant. We therefore compared reactivity to methacholine and exercise in children with asthma and other forms of chronic lung disease.
Methods
Ninety three young subjects, 78 under 16 years and 15 children aged 16-24, attending the pediatric respiratory diseases clinic underwent methacholine and exercise challenges during January 1989-July 1990. The patients were not selected specifically for the study and had been referred by their physician for investigation of lung function. For the purpose of the present analysis they were divided into three groups according to the clinical diagnosis established at not less than two visits to the clinic and in most cases by several visits over several months. Pertinent clinical details are given in table 1. The asthmatic group consisted of 52 subjects (mean age 117 (SD 3 9) years, eight over 16 years) with a typical history, reversible airways obstruction documented by lung function testing, and a response to antiasthma medication. All had a normal chest radiograph between attacks and no evidence of other lung disease. The chronic lung disease group consisted of 22 children (mean age 11 4 (3 1) years, two over 16), seven of whom had cystic fibrosis, five unexplained recurrent pneumonia but no evidence of immunodeficiency or other underlying cause, six chronic obstructive lung disease following documented or presumed adenoviral bronchiolitis, two bronchiectasis, and two the immotile cilia syndrome.
The diagnosis was established in each child, by appropriate investigations, including sweat tests, computed tomography, nasal mucosa biopsy, and a trial of antiasthma medication to which there was no response. The control group consisted of 19 children (mean age 14 4 (4-1) years, five over 16), who had presented with chronic cough but in whom investigation and follow up failed to show any evidence of organic lung disease and in whom all symptoms disappeared. Lung function at rest was usually enough to allow the FEV, to return to within 10% of the baseline value of the first challenge. In only seven instances (all from the asthma group) did the prechallenge baselines differ by more than 10% and in two of these instances the challenges were on different days. The baseline FEV, was more than 10% higher before the methacholine challenge in four instances and before the exercise challenge in three. The results of the exercise and methacholine challenges were not known to the investigator (SG) who allocated the children to the three diagnostic groups: he worked from the case notes without reference to the laboratory records.
Bronchial challenges were performed only if resting FEV, was at least 60% of predicted. In the asthmatic patients all bronchodilator medications other than theophylline preparations were omitted for at least eight hours before the challenges and sodium cromoglycate for at least 12 hours. Theophylline and corticosteroids were continued in normal doses throughout both challenges. All the control subjects and all but one of the children with chronic lung disease were not being treated with antiasthma medication on a regular basis and had not received any medication for at least 24 hours before the challenges. One patient with the immotile cilia syndrome was being treated with slow release theophylline and inhaled corticosteroids at the time of the challenges as she had been thought to have asthma and the nasal mucosa biopsy result was not yet available. The reason for the tests was explained to the parents and the child, whose consent was obtained in conformity with the normal practice of this institution.
METHACHOLINE CHALLENGES
Methacholine was administered by the method described by Cockroft et al'9 for adults. Increasing concentrations of methacholine were given for two minutes during tidal breathing, with measurement of lung function for three minutes after each inhalation. The inspirate was generated by a nebuliser (Hudson Up-draft Nebulizer, Temecula, California) connected to a CR 60 compressor (Medic-Aid Ltd, Pagham, UK) with an airflow rate of 6 1/min. The nebuliser chamber was filled with 2-0 ml of freshly prepared methacholine solution. Under the conditions of the test the nebuliser chamber decreased in weight by an average of 0-28 g in two minutes. The nebuliser was connected through a one way valve system to a mouth piece, through which the child breathed while wearing a nose clip. Lung function was measured with a pneumotachograph based system (Vitalograph Compact, Buckingham, UK), the highest value of FEV, recorded from two or three efforts being used.
Phosphate buffer (placebo) was inhaled initially and all subsequent changes in FEV, were related to the post-buffer value. The initial methacholine concentration (0-03 mg/ml) was followed by doubling concentrations until the FEV, had fallen by more than 20% or the concentration of 8 0 mg/ml had been given. The concentrations of methacholine causing a 20% fall in FEV, from the post-placebo value (PC20) were derived from a plot of FEV, on log methacholine concentration. If the FEV, had not fallen by 20% after the 8-0 mg/ml dose a PC20 of 16 mg/ml was assigned.
EXERCISE CHALLENGE All subjects carried out exercise for six minutes on a treadmill as described previously. 20 The treadmill was set with a slope of 10°and the subjects ran continuously at a speed of 5 kph. This produced a heart rate of 160-180/ minute and represented about two thirds of the physical work capacity. FEV, (the highest of two or three measurements) was measured before exercise and three, five, 10, 15, and 20 minutes afterwards. The challenge was performed in an air conditioned laboratory and the subject breathed room air with a temperature of 22-26°C and a relative humidity of 48-56%. The climatic conditions did not vary systematically between the challenges in the different groups. The result of the exercise challenge was calculated as the greatest fall in FEV, after exercise expressed as a percentage of the pre-exercise baseline value (A FEVI). There was no significant difference in resting FEVy values before both challenges than the control group and both the asthmatic patients and those with chronic lung disease had significantly lower maximum mid expiratory flow rates (MEF5O) than the control group before the challenges. Although the mean PC20 methacholine values in the three groups differed very significantly (ANOVA, p < 0 0001), there was considerable overlap between the values seen in those with asthma and in those with chronic lung disease. The mean a FEV, also differed very significantly between the groups (ANOVA, p < 0-0001), but in this case there was very little overlap between the asthmatic children and the other two groups.
A normal range of response for each challenge was calculated from the results of the control group (see figs 1 and 2). The lower limit of normal for PC20 methacholine was taken as the mean minus 2 log SD (2-66 mg/ml) and the upper limit of normal for a FEV, as the mean plus 2 SD (8-2%). In the asthmatic group 49 of the 52 subjects (94%) had a PC20 below the lower limit of normal, as did 18 of the 22 subjects (82%) with chronic lung disease. The a FEV1 after exercise was greater than the upper limit of normal in 41 of the 52 asthmatic subjects (79%), but none of those with chronic lung disease had a a FEV, after exercise that was above the normal range.
Discussion
In the present study bronchial hyperreactivity to methacholine was present in most of the young people with asthma or chronic lung disease, whereas hyperreactivity to exercise was present only in those with asthma. We know of no similar comparison of bronchial responsiveness to methacholine and exercise in children with asthma and in other chronic lung diseases. Previous studies have compared the sensitivity of asthmatic children to these different challenges and in general have found, Our control group consisted of 19 subjects in whom no pulmonary disease could be found. The reactivity of these children to both methacholine and exercise was well within the normal range reported in other studies using the same techniques.8 ""' By taking a difference of 2 SD to define normality we maximised the chance of a sick child falling within the normal range. Despite much work the pathogenesis of exercise induced asthma is still disputed.28 There now seems little doubt that cooling or drying of the airways, or both, together with an exercise or hyperventilation related factor, act as the trigger mechanism. The effector mechanism is thought to be contraction of airway smooth muscle, though it has been suggested that reactive hyperaemia could cause the airways obstruction.29 There are, however, arguments against this,2830 including the fact that bronchoconstriction often occurs during exercise before the airways have had time to rewarm. The intermediary pathway between stimulus and effect is less certain but circumstantial evidence suggests that chemical mediators may play a part.3""33 Methacholine and histamine are presumably acting mainly on bronchial smooth muscle. They could, in theory, also trigger mediator release but a rise in one mediator (neutrophil chemotactic factor) -has not been recorded in the response to challenge with histamine or methacholine and the response to these stimuli is not blocked by sodium cromoglycate.3233 The difference between exercise on the one hand and methacholine and histamine on the other may lie in the presence of an intermediary pathway for a response to exercise but not to methacholine or histamine, while the final common pathway, airway smooth muscle contraction, is similar.
Increased responsiveness of bronchial smooth muscle could result from several factors, including damage to the bronchial epithelium from any cause, exposing subepithelial nerve endings and removing epithelium derived relaxant factor.3435 Such damage occurs in asthma but also occurs with other chronic inflammatory processes in the airways; transient bronchial hyperreactivity can be induced by the inhalation of ozone or other pollutants that damage the mucosa. Such a mechanism could explain the hyperreactivity to methacholine seen in our patients with chronic lung disease. If, on the other hand, exercise induced asthma depended on an intermediary pathway specific to asthma, an abnormal response to exercise would be expected only in asthma whereas an abnormal response to methacholine would be seen in both asthma and chronic lung disease. Increased responsiveness to histamine has been found in subjects with previous asthma but no symptoms at a time when they no longer respond to exercise,36 37 which suggests that "growing out of asthma" might depend on a loss or diminution of the intermediary pathway. We cannot explain why 21% of our asthmatic patients failed to respond to exercise, though this is similar to the proportion of non-responders reported by others.2' The factors that influence the net effect of an exercise challenge on an asthmatic patient include, among others, climatic conditions, presence or absence of allergenic stimulation, pollution levels, and medications; so some unpredictability is to be expected.
In our study bronchial hyperresponsiveness to methacholine was common to all kinds of chronic lung disease in childhood, whereas an abnormal response to exercise occurred only in asthma. Although the response to exercise in asthma was not universal (79% responded), the use of both types of challenge helps in the differential diagnosis of asthma and other types of chronic lung disease in children.
